Giseli Capaci Rodrigues

Cloning, Characterization, and Sulfonamide and Thiol Inhibition Studies of an α-Carbonic Anhydrase from <i>Trypanosoma cruzi</i>, the Causative Agent of Chagas Disease

Peiwen Pan, Alane Beatriz Vermelho, Giseli Capaci Rodrigues et al. · Journal of Medicinal Chemistry · 2013 · 103 citations · Full text

Life Sciences, Biochemistry, Chemistry +17

Design, Synthesis, and Evaluation of Hydroxamic Acid Derivatives as Promising Agents for the Management of Chagas Disease

Giseli Capaci Rodrigues, Marcelo T. Bozza, Peiwen Pan et al. · Journal of Medicinal Chemistry · 2013 · 81 citations · Full text

Veterinary Medicine, Pharmacology, Pharmacotherapy +17

Why hasn’t there been more progress in new Chagas disease drug discovery?

Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Claudiu T. Supuran · Expert Opinion on Drug Discovery · 2019 · 75 citations

Veterinary Medicine, Infectious Diseases, Pharmacology +17

Hydroxamic acid derivatives: a promising scaffold for rational compound optimization in Chagas disease

Dayanne da Rocha de Menezes, Cláudia M. Calvet, Giseli Capaci Rodrigues et al. · Journal of Enzyme Inhibition and Medicinal Chemistry · 2015 · 31 citations · Full text

Veterinary Medicine, Medicinal Chemistry, Pharmacology +17

Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs?

Alane Beatriz Vermelho, Giseli Capaci Rodrigues, Alessio Nocentini et al. · Expert Opinion on Drug Discovery · 2022 · 15 citations

Veterinary Medicine, Medicinal Chemistry, Pharmacology +17